Filtros : "Indexado no Index Medicus" "Clinical Endocrinology" Removido: "Revista do Instituto de Medicina Tropical de São Paulo" Limpar

Filtros



Refine with date range


  • Source: Clinical Endocrinology. Unidade: FM

    Subjects: DENSIDADE ÓSSEA, NEOPLASIA ENDÓCRINA MÚLTIPLA, PARATIREOIDECTOMIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      COUTINHO, Flavia L. et al. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. Clinical Endocrinology, v. 72, n. 4, p. 462-468, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2009.03672.x. Acesso em: 06 jun. 2024.
    • APA

      Coutinho, F. L., Lourenço Jr., D. M., Toledo, R. A., Montenegro, F. L. M., Correia-Deur, J. E. M., & Toledo, S. P. A. (2010). Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. Clinical Endocrinology, 72( 4), 462-468. doi:10.1111/j.1365-2265.2009.03672.x
    • NLM

      Coutinho FL, Lourenço Jr. DM, Toledo RA, Montenegro FLM, Correia-Deur JEM, Toledo SPA. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy [Internet]. Clinical Endocrinology. 2010 ; 72( 4): 462-468.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2009.03672.x
    • Vancouver

      Coutinho FL, Lourenço Jr. DM, Toledo RA, Montenegro FLM, Correia-Deur JEM, Toledo SPA. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy [Internet]. Clinical Endocrinology. 2010 ; 72( 4): 462-468.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2009.03672.x
  • Source: Clinical Endocrinology. Unidade: FM

    Subjects: HIDROXILASE (DEFICIÊNCIA), HIPERPLASIA SUPRARRENAL CONGÊNITA, SENSIBILIDADE E ESPECIFICIDADE, MENOPAUSA, BIOLOGIA MOLECULAR, GENÓTIPOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBOSA, Flávia A. Costa et al. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency. Clinical Endocrinology, v. 73, n. 6, p. 700-706, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2010.03871.x. Acesso em: 06 jun. 2024.
    • APA

      Barbosa, F. A. C., Fernandes, V. F. T., Carvalho, valdemir M., Nakamura, O. H., Moura, V., Vieira, J. G. H., et al. (2010). Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency. Clinical Endocrinology, 73( 6), 700-706. doi:10.1111/j.1365-2265.2010.03871.x
    • NLM

      Barbosa FAC, Fernandes VFT, Carvalho valdemir M, Nakamura OH, Moura V, Vieira JGH, Bachega TASS, Kater CE. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency [Internet]. Clinical Endocrinology. 2010 ; 73( 6): 700-706.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2010.03871.x
    • Vancouver

      Barbosa FAC, Fernandes VFT, Carvalho valdemir M, Nakamura OH, Moura V, Vieira JGH, Bachega TASS, Kater CE. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency [Internet]. Clinical Endocrinology. 2010 ; 73( 6): 700-706.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2010.03871.x
  • Source: Clinical Endocrinology. Unidade: FM

    Subjects: GLÂNDULA PITUITÁRIA (SECREÇÃO), HORMÔNIOS HIPOFISÁRIOS (ANÁLISE), GLÂNDULA PITUITÁRIA (PATOLOGIA)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELO, Maria Edna et al. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe. Clinical Endocrinology, v. 66, p. 95-102, 2007Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2006.02692.x. Acesso em: 06 jun. 2024.
    • APA

      Melo, M. E., Marui, S., Carvalho, L. R., Arnhold, I. J., Leite, C. da C., Mendonça, B. B., & Knoepfelmacher, M. (2007). Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe. Clinical Endocrinology, 66, 95-102. doi:10.1111/j.1365-2265.2006.02692.x
    • NLM

      Melo ME, Marui S, Carvalho LR, Arnhold IJ, Leite C da C, Mendonça BB, Knoepfelmacher M. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe [Internet]. Clinical Endocrinology. 2007 ; 66 95-102.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2006.02692.x
    • Vancouver

      Melo ME, Marui S, Carvalho LR, Arnhold IJ, Leite C da C, Mendonça BB, Knoepfelmacher M. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe [Internet]. Clinical Endocrinology. 2007 ; 66 95-102.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2006.02692.x
  • Source: Clinical Endocrinology. Unidade: FM

    Subjects: CRESCIMENTO, FEN'PTIPOS, MUTAÇÃO GENÉTICA, RAQUITISMO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JORGE, Alexander A. L. et al. Shox mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: Frequency and phenotypic variability. Clinical Endocrinology, v. 66, p. 130-135, 2007Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2006.02698.x. Acesso em: 06 jun. 2024.
    • APA

      Jorge, A. A. L., Souza, S. C., Nishi, M. Y., Billerbeck, A. E., Libório, D. C. C., Kim, C. A., et al. (2007). Shox mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: Frequency and phenotypic variability. Clinical Endocrinology, 66, 130-135. doi:10.1111/j.1365-2265.2006.02698.x
    • NLM

      Jorge AAL, Souza SC, Nishi MY, Billerbeck AE, Libório DCC, Kim CA, Arnhold IJP, Mendonça BB. Shox mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: Frequency and phenotypic variability [Internet]. Clinical Endocrinology. 2007 ; 66 130-135.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2006.02698.x
    • Vancouver

      Jorge AAL, Souza SC, Nishi MY, Billerbeck AE, Libório DCC, Kim CA, Arnhold IJP, Mendonça BB. Shox mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: Frequency and phenotypic variability [Internet]. Clinical Endocrinology. 2007 ; 66 130-135.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2006.02698.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Subjects: HORMÔNIOS TIREOIDIANOS, DOENÇAS GENÉTICAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MAGALHÃES, Patrícia Künzle Ribeiro et al. Clinical features and genetic analysis of four brazilian kindreds with resistance to thyroid hormone. Clinical Endocrinology, v. 67, p. 748-753, 2007Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2007.02956.x. Acesso em: 06 jun. 2024.
    • APA

      Magalhães, P. K. R., Daré, G. L. R., Santos, S. R. dos, Nogueira, C. R., Castro, M. de, & Maciel, L. M. Z. (2007). Clinical features and genetic analysis of four brazilian kindreds with resistance to thyroid hormone. Clinical Endocrinology, 67, 748-753. doi:10.1111/j.1365-2265.2007.02956.x
    • NLM

      Magalhães PKR, Daré GLR, Santos SR dos, Nogueira CR, Castro M de, Maciel LMZ. Clinical features and genetic analysis of four brazilian kindreds with resistance to thyroid hormone [Internet]. Clinical Endocrinology. 2007 ; 67 748-753.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.02956.x
    • Vancouver

      Magalhães PKR, Daré GLR, Santos SR dos, Nogueira CR, Castro M de, Maciel LMZ. Clinical features and genetic analysis of four brazilian kindreds with resistance to thyroid hormone [Internet]. Clinical Endocrinology. 2007 ; 67 748-753.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.02956.x
  • Source: Clinical Endocrinology. Unidade: FM

    Subjects: ENDOCRINOPATIAS (PATOLOGIA;GENÉTICA), NEOPLASIAS (PATOLOGIA;GENÉTGICA), GLÂNDULAS ENDÓCRINAS (PATOLOGIA), MUTAÇÃO GENÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TOLEDO, Rodrigo A. et al. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1. Clinical Endocrinology, v. 67, p. 377-384, 2007Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2007.02895.x. Acesso em: 06 jun. 2024.
    • APA

      Toledo, R. A., Lourenço Junior, D. M., Coutinho, F. L., Quedas, E., Mackowiack, I., Machado, M. C. C., et al. (2007). Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1. Clinical Endocrinology, 67, 377-384. doi:10.1111/j.1365-2265.2007.02895.x
    • NLM

      Toledo RA, Lourenço Junior DM, Coutinho FL, Quedas E, Mackowiack I, Machado MCC, Montenegro F, Cunha-Neto MBC, Liberman B, Pereira MAA, Correa PHS, Toledo SPA. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1 [Internet]. Clinical Endocrinology. 2007 ; 67 377-384.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.02895.x
    • Vancouver

      Toledo RA, Lourenço Junior DM, Coutinho FL, Quedas E, Mackowiack I, Machado MCC, Montenegro F, Cunha-Neto MBC, Liberman B, Pereira MAA, Correa PHS, Toledo SPA. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1 [Internet]. Clinical Endocrinology. 2007 ; 67 377-384.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.02895.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Subjects: OSTEOPATIAS METABÓLICAS, COLELITÍASE, PEDIATRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAVEIRA, Adriana Távora de Albuquerque et al. Impairment of bone mass development in children with chronic cholestatic liver disease. Clinical Endocrinology, v. 66, p. 518-523, 2007Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2007.02765.x. Acesso em: 06 jun. 2024.
    • APA

      Taveira, A. T. de A., Fernandes, M. I. M., Galvão, L. C., Sawamura, R., Vieira, E. de M., & Paula, F. J. A. de. (2007). Impairment of bone mass development in children with chronic cholestatic liver disease. Clinical Endocrinology, 66, 518-523. doi:10.1111/j.1365-2265.2007.02765.x
    • NLM

      Taveira AT de A, Fernandes MIM, Galvão LC, Sawamura R, Vieira E de M, Paula FJA de. Impairment of bone mass development in children with chronic cholestatic liver disease [Internet]. Clinical Endocrinology. 2007 ; 66 518-523.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.02765.x
    • Vancouver

      Taveira AT de A, Fernandes MIM, Galvão LC, Sawamura R, Vieira E de M, Paula FJA de. Impairment of bone mass development in children with chronic cholestatic liver disease [Internet]. Clinical Endocrinology. 2007 ; 66 518-523.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.02765.x
  • Source: Clinical Endocrinology. Unidade: FM

    Subjects: FENÓTIPOS, HIPERPLASIA SUPRARRENAL CONGÊNITA, HIDROXILASE (ATIVIDADE)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAUJO, Rogério S. et al. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clinical Endocrinology, v. 62, p. 132-136, 2005Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2005.02184.x. Acesso em: 06 jun. 2024.
    • APA

      Araujo, R. S., Billerbeck, A. E. C., Madureira, G., Mendonça, B. B., & Bachega, T. A. S. S. (2005). Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clinical Endocrinology, 62, 132-136. doi:10.1111/j.1365-2265.2005.02184.x
    • NLM

      Araujo RS, Billerbeck AEC, Madureira G, Mendonça BB, Bachega TASS. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation [Internet]. Clinical Endocrinology. 2005 ; 62 132-136.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2005.02184.x
    • Vancouver

      Araujo RS, Billerbeck AEC, Madureira G, Mendonça BB, Bachega TASS. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation [Internet]. Clinical Endocrinology. 2005 ; 62 132-136.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2005.02184.x
  • Source: Clinical Endocrinology. Unidade: ICB

    Assunto: HISTOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLER, Gisele et al. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis. Clinical Endocrinology, v. 62, p. 509-511, 2005Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2005.02235.x. Acesso em: 06 jun. 2024.
    • APA

      Oler, G., Ebina, K. N., Michaluart Jr, P., Kimura, E. T., & Cerutti, J. (2005). Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis. Clinical Endocrinology, 62, 509-511. doi:10.1111/j.1365-2265.2005.02235.x
    • NLM

      Oler G, Ebina KN, Michaluart Jr P, Kimura ET, Cerutti J. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis [Internet]. Clinical Endocrinology. 2005 ; 62 509-511.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2005.02235.x
    • Vancouver

      Oler G, Ebina KN, Michaluart Jr P, Kimura ET, Cerutti J. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis [Internet]. Clinical Endocrinology. 2005 ; 62 509-511.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2005.02235.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Subjects: ENDOCRINOPATIAS, PEDIATRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CUNHA, Heloisa Marcelina et al. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinical Endocrinology, v. 61, p. 94-101, 2004Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2004.02075.x. Acesso em: 06 jun. 2024.
    • APA

      Cunha, H. M., Elias, L. L. K., Camacho-Hubner, C., Moreira, A. C., & Martinelli Júnior, C. E. (2004). Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinical Endocrinology, 61, 94-101. doi:10.1111/j.1365-2265.2004.02075.x
    • NLM

      Cunha HM, Elias LLK, Camacho-Hubner C, Moreira AC, Martinelli Júnior CE. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency [Internet]. Clinical Endocrinology. 2004 ; 61 94-101.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.02075.x
    • Vancouver

      Cunha HM, Elias LLK, Camacho-Hubner C, Moreira AC, Martinelli Júnior CE. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency [Internet]. Clinical Endocrinology. 2004 ; 61 94-101.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.02075.x
  • Source: Clinical Endocrinology. Unidades: FCF, FM

    Subjects: DIABETES MELLITUS, LIPOPROTEÍNAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WAJCHENBERG, Bernardo Leo et al. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons. Clinical Endocrinology, v. 61, n. 3, p. 347-352, 2004Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2004.02103.x. Acesso em: 06 jun. 2024.
    • APA

      Wajchenberg, B. L., Amâncio, R. F., Santomauro, A. T., & Maranhão, R. C. (2004). Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons. Clinical Endocrinology, 61( 3), 347-352. doi:10.1111/j.1365-2265.2004.02103.x
    • NLM

      Wajchenberg BL, Amâncio RF, Santomauro AT, Maranhão RC. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons [Internet]. Clinical Endocrinology. 2004 ; 61( 3): 347-352.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.02103.x
    • Vancouver

      Wajchenberg BL, Amâncio RF, Santomauro AT, Maranhão RC. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons [Internet]. Clinical Endocrinology. 2004 ; 61( 3): 347-352.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.02103.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Assunto: ENDOCRINOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CASTRO, Margaret et al. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Clinical Endocrinology, v. 59, p. 800-805, 2003Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.2003.01908.x. Acesso em: 06 jun. 2024.
    • APA

      Castro, M., Elias, L. L. K., Elias, P. C. L., & Moreira, A. C. (2003). A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Clinical Endocrinology, 59, 800-805. doi:10.1046/j.1365-2265.2003.01908.x
    • NLM

      Castro M, Elias LLK, Elias PCL, Moreira AC. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome [Internet]. Clinical Endocrinology. 2003 ; 59 800-805.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2003.01908.x
    • Vancouver

      Castro M, Elias LLK, Elias PCL, Moreira AC. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome [Internet]. Clinical Endocrinology. 2003 ; 59 800-805.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2003.01908.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Assunto: ENDOCRINOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ELIAS, Paula Conde Lamparelli et al. Progressive decline of vasopressin secretion in familial autossomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clinical Endocrinology, v. 39, p. 511-518, 2003Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.2003.01834.x. Acesso em: 06 jun. 2024.
    • APA

      Elias, P. C. L., Elias, L. L. K., Torres, N., Moreira, A. C., Antunes-Rodrigues, J., & Castro, M. de. (2003). Progressive decline of vasopressin secretion in familial autossomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clinical Endocrinology, 39, 511-518. doi:10.1046/j.1365-2265.2003.01834.x
    • NLM

      Elias PCL, Elias LLK, Torres N, Moreira AC, Antunes-Rodrigues J, Castro M de. Progressive decline of vasopressin secretion in familial autossomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene [Internet]. Clinical Endocrinology. 2003 ; 39 511-518.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2003.01834.x
    • Vancouver

      Elias PCL, Elias LLK, Torres N, Moreira AC, Antunes-Rodrigues J, Castro M de. Progressive decline of vasopressin secretion in familial autossomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene [Internet]. Clinical Endocrinology. 2003 ; 39 511-518.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2003.01834.x
  • Source: Clinical Endocrinology. Unidades: FMRP, FM

    Assunto: ENDOCRINOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ANTONINI, S. R. R. et al. Glucocorticoid receptor gene polymorphysms in ACTH-secreting pituitary tumors. Clinical Endocrinology, v. 57, p. 657-662, 2002Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.2002.01639.x. Acesso em: 06 jun. 2024.
    • APA

      Antonini, S. R. R., Latronicot, A. C., ELIAS, L. L. K., Machado, H. R., Liberman, B., Mendonça, B. B. de, et al. (2002). Glucocorticoid receptor gene polymorphysms in ACTH-secreting pituitary tumors. Clinical Endocrinology, 57, 657-662. doi:10.1046/j.1365-2265.2002.01639.x
    • NLM

      Antonini SRR, Latronicot AC, ELIAS LLK, Machado HR, Liberman B, Mendonça BB de, Moreira AC, Castro M de. Glucocorticoid receptor gene polymorphysms in ACTH-secreting pituitary tumors [Internet]. Clinical Endocrinology. 2002 ; 57 657-662.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2002.01639.x
    • Vancouver

      Antonini SRR, Latronicot AC, ELIAS LLK, Machado HR, Liberman B, Mendonça BB de, Moreira AC, Castro M de. Glucocorticoid receptor gene polymorphysms in ACTH-secreting pituitary tumors [Internet]. Clinical Endocrinology. 2002 ; 57 657-662.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2002.01639.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Subjects: ENDOCRINOLOGIA, HORMÔNIOS (METABOLISMO), DESENVOLVIMENTO FÍSICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARUI, S. et al. Mutations in the type II 3'beta'-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Clinical Endocrinology, v. 52, p. 67-75, 2000Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.2000.00873.x. Acesso em: 06 jun. 2024.
    • APA

      Marui, S., Castro, M. de, Latronico, A. C., Elias, L. L. K., Arnhold, I. J. P., Moreira, A. C., & Mendonça, B. B. (2000). Mutations in the type II 3'beta'-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Clinical Endocrinology, 52, 67-75. doi:10.1046/j.1365-2265.2000.00873.x
    • NLM

      Marui S, Castro M de, Latronico AC, Elias LLK, Arnhold IJP, Moreira AC, Mendonça BB. Mutations in the type II 3'beta'-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls [Internet]. Clinical Endocrinology. 2000 ; 52 67-75.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2000.00873.x
    • Vancouver

      Marui S, Castro M de, Latronico AC, Elias LLK, Arnhold IJP, Moreira AC, Mendonça BB. Mutations in the type II 3'beta'-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls [Internet]. Clinical Endocrinology. 2000 ; 52 67-75.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.2000.00873.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Subjects: ENDOCRINOLOGIA, PEDIATRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ANTONINI, Sonir Roberto Rauber e JORGE, Salim Moysés e MOREIRA, Ayrton Custódio. The emergence of salivary cortisol circadin rhythm and its relationship to sleep activity in preterm infants. Clinical Endocrinology, v. 52, p. 423-426, 2000Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2000.tb00561.x. Acesso em: 06 jun. 2024.
    • APA

      Antonini, S. R. R., Jorge, S. M., & Moreira, A. C. (2000). The emergence of salivary cortisol circadin rhythm and its relationship to sleep activity in preterm infants. Clinical Endocrinology, 52, 423-426. doi:10.1111/j.1365-2265.2000.tb00561.x
    • NLM

      Antonini SRR, Jorge SM, Moreira AC. The emergence of salivary cortisol circadin rhythm and its relationship to sleep activity in preterm infants [Internet]. Clinical Endocrinology. 2000 ; 52 423-426.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2000.tb00561.x
    • Vancouver

      Antonini SRR, Jorge SM, Moreira AC. The emergence of salivary cortisol circadin rhythm and its relationship to sleep activity in preterm infants [Internet]. Clinical Endocrinology. 2000 ; 52 423-426.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/j.1365-2265.2000.tb00561.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Subjects: ENDOCRINOPATIAS, ENDOCRINOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINELLI, Carlos Eduardo et al. Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children. Clinical Endocrinology, v. 50, p. 767-774, 1999Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.1999.00724.x. Acesso em: 06 jun. 2024.
    • APA

      Martinelli, C. E., Yateman, M., Cotterill, A. M., Moreira, A. C., & Camacho-Hübsner, C. (1999). Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children. Clinical Endocrinology, 50, 767-774. doi:10.1046/j.1365-2265.1999.00724.x
    • NLM

      Martinelli CE, Yateman M, Cotterill AM, Moreira AC, Camacho-Hübsner C. Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children [Internet]. Clinical Endocrinology. 1999 ; 50 767-774.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.1999.00724.x
    • Vancouver

      Martinelli CE, Yateman M, Cotterill AM, Moreira AC, Camacho-Hübsner C. Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children [Internet]. Clinical Endocrinology. 1999 ; 50 767-774.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.1999.00724.x
  • Source: Clinical Endocrinology. Unidade: FMRP

    Subjects: ENDOCRINOPATIAS, ENDOCRINOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINELLI JÚNIOR, Carlos Eduardo et al. Salivary cortisol for screening of Cushing's syndrome in children. Clinical Endocrinology, v. 51, p. 67-71, 1999Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.1999.00749.x. Acesso em: 06 jun. 2024.
    • APA

      Martinelli Júnior, C. E., Sader, S. L., Oliveira, E. B. de, Daneluzzi, J. C., & Moreira, A. C. (1999). Salivary cortisol for screening of Cushing's syndrome in children. Clinical Endocrinology, 51, 67-71. doi:10.1046/j.1365-2265.1999.00749.x
    • NLM

      Martinelli Júnior CE, Sader SL, Oliveira EB de, Daneluzzi JC, Moreira AC. Salivary cortisol for screening of Cushing's syndrome in children [Internet]. Clinical Endocrinology. 1999 ; 51 67-71.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.1999.00749.x
    • Vancouver

      Martinelli Júnior CE, Sader SL, Oliveira EB de, Daneluzzi JC, Moreira AC. Salivary cortisol for screening of Cushing's syndrome in children [Internet]. Clinical Endocrinology. 1999 ; 51 67-71.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2265.1999.00749.x

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024